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Tuoxin Cao

Daily Administration of Ibuprofen
Modifies Neuroinflammation Gene
Expression, but Not Neuroplasticity
Gene Expression in Traumatic
Brain Injured Rats
Introduction
Each year there are at least 1.4 million civilian traumatic
brain injury (TBI) incidents, with most as a result of a moderate
level of injury and being treated in the emergency department
(Langlois and Sattin 2005). The post-traumatic morbidity is
likely to result from secondary molecular, biochemical and
cellular events that cause additional neuronal, glial and vascular
injuries across multiple brain areas (Thompson, Gibson et al.,
2006; Farkas and Povlishock 2007).
One of the primary histopathological consequences
associated with TBI is microglial activation and ensuing
neuroinflammation(Csuka, Hans et al. 2000). Inflammation
in neurodegenerative conditions can be both detrimental and
beneficial(Gensel, Nakamura et al. 2009). Inflammation can
clear dead or dying tissue. On the other hand, previous studies
in spinal cord injury and Alzheimer diseases have shown that
microglia activation, especially the alternative activation of
microglia, can be one factor that promotes neuroplasticity
and potentially affect the recovery of the patient (Donnelly
and Popovich, 2008; Popovich and Longbrake, 2008; Colton,
2009; Colton and Wilcock, 2009; Gensel, Nakamura et al.,
2009; Kigerl, Gensel et al., 2009). We hypothesize that the
primary mechanical forces of TBI initiate microglia activation,
and therefore anti-inflammatory treatments would reduce
microglia activation, helping to control post-traumatic
neuroplasticity. Here, we examine the post-traumatic
microglia activation states: classical activation associated with
neurotoxicity, alternative activation associated with recovery,
and acquired deactivation associated with anti-inflammatory
response (Colton and Wilcock, 2009; Gensel, Nakamura et al.,
2009). Also, we examine the ability of the anti-inflammatory
ibuprofen to modulate microglial activation and neuroplasticity
gene expression using real-time PCR.

Experimental Design
Adult male Sprague-Dawley rats (350–375 g) were
subjected to midline fluid percussion injury (FPI) consistent
with methods described previously (Lifshitz, Kelley et al.,
2007; Lifshitz, 2008; Hosseini and Lifshitz, 2009; McNamara,
Lisembee et al., 2010). A craniotomy was performed and the
injury hub was secured on the skull of rats under isoflurane
anesthesia. As each rat’s reflex response returned, a sham injury
(the animal is connected to the injury device, but no injury

introduced) or a moderate (1.9-2.0 atm) FPI was introduced
to each rat. Uninjured (n=12) and injured rats (n=16) were
treated with daily administration of either saline or ibuprofen
(20mg/kg; i.p. injection). At 7 days post-injury, each animal
was euthanized and tissue biopsies of the somatosensory cortex
and thalamus were taken from the coronal brain section.
From the tissue, the mRNA was isolated (FastPrep®-24 sample
preparation system, M.P. Biomedicals and MagMax™ Express,
Applied Biosystems Inc.), quantified (NanoDrop ND-1000
spectrophotometer), and then converted to complementary
DNA (cDNA; High Capacity RNA-to-cDNA Kit, Applied
Biosystems Inc.). The cDNA was used as a template for
quantitative real-time PCR using commercially-available gene
expression assays (Taqman® Gene Expression Assay, Applied
Biosystems). Within each animal, expression of microglia
activation marker (TSPO), classical activation marker (CD45),
alternative activation marker (Arg1), acquired deactivation
marker (TGFß1) and neuro-plasticity markers (GAP43,
Synaptophysin) were normalized to the gene expression level
of endogenous control, 18s rRNA (Colton, 2009; Colton and
Wilcock, 2009; Cook, Vink et al. 2009; Gensel, Nakamura
et al., 2009; Harris, Reeves et al., 2009; Kigerl, Gensel et
al., 2009). Gene expression in each group was averaged and
normalized to the sham-vehicle treated group using 2-ΔΔCT
method (Livak and Schmittgen, 2001).
Gene expression in all other groups was expressed as the
percentage change of sham-vehicle group. Peirce’s criterion
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Figure 2: Neuroplasticity gene expression was not affected by brain
injury or ibuprofen treatment in the cortex or thalamus (n=5-6/
group). The sham vehicle-treated and sham ibuprofen-treated
groups were combined into a single sham group after confirming no
significant difference between groups.

was used to identify outliers in the data sets (Ross 2003). To
maximize statistical power, sham-saline treated and shamibuprofen treated groups were combined into one sham
group after confirming no significant differences between the
two groups by student t-test. All statistical assessments were
performed using one-way analysis of variance (ANOVA)
followed by Tukey-Kramer multiple comparisons test using
GraphPad InStat statistical software. Results are considered
significant if p < 0.05. All data are presented as mean ±
standard error of the mean (SEM).
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Figure 1:Post-traumatic inflammatory gene expression after
anti-inflammatory treatment. 7 days after fluid percussion
injury (FPI) are compared between sham, injured-saline
treated, and injured-ibuprofen treated rats (n= 5-6 per
group). In the cortex, gene expression of both TSPO and
TGFB1 increased after ibuprofen treatment compared to
sham. Injury-induced increases in CD45 gene expression at
7 days post-FPI was not affected by ibuprofen treatment.
In the thalamus, gene expression indicates significantly
increased classical (TSPO and CD45) and anti-inflammatory
(TGFB1) microglial activation at 7 days post-FPI. Ibuprofen
treatment reduced gene expression levels TSPO, CD45 and
TGFB1 such that they are no longer significantly different
from sham. *, p < 0.05; **, p < 0.01 compared to sham.
TSPO: translocator protein 18 kDa
CD45: protein tyrosine phosphatase receptor type C
TGFßI: transforming growth factor ß1

Gene expression in the two brain regions responded
differently to anti-inflammation treatment. In the cortex,
daily ibuprofen administration was ineffective in attenuating
the injury-induced increase in classical microglia activation
and acquired microglia deactivation (Figure 1). TSPO gene
expression remained significantly elevated above sham in the
ibuprofen-treated brain-injured animals (F(2,15) = 5.123; p
= 0.0201).TGFß1 gene expression was increased significantly
in injured ibuprofen-treated animals compared to sham
animals (F(2,12) = 6.749; p = 0.0109), suggesting increased
anti-inflammatory gene expression following ibuprofen
administration. Injury-induced increases in CD45 gene
expression at 7 days post-FPI was not significantly affected by
ibuprofen treatment, whereas ibuprofen treatment increased
TSPO and TGFß1 gene expression.
In VPM, the fourfold significant increase in TSPO gene
expression in brain-injured saline-treated animals was downregulated by the ibuprofen administration to the level where
no significant change was found compared to the sham group
(F(2,14) = 6.754; p = 0.0088). Similar results were obtained
for the gene expression of CD45 (F(2,13) = 8.160; p =
0.0051) and TGFß1 (F(2,12) = 4.844; p = 0.0287); the gene
expression increased significantly with saline treatment, while
administration of ibuprofen down-regulated gene expression.
As found previously, arginase 1 gene expression was not
significantly different between sham animals, FPI-injured
animals and FPI-injured ibuprofen-treated animals (S1BF:
F(2,14) = 0.4881, p = 0.6239; VPM: F(2,14) = 0.6358, p =
0.5441)
Even though anti-inflammatory treatment resulted in
various changes in both classical activation and acquired
deactivation in cortex and thalamus, no significant change in
neuroplasticity gene expression was observed in either brain
region as the result of ibuprofen administration (Figure 2).
Classical and acquired activation of microglia may not be
directly associated with neuroplasticity gene expression.

Discussion
Results of TSPO gene expression suggest there is
increased microglia activation in the cortex and reduced
microglial activation in the thalamus when ibuprofen is
administered. In the cortex, increased TGFß1 gene expression
occurs concomitantly with an increase in TSPO gene
expression, suggesting interplay between inflammatory and
anti-inflammatory responses. Also the ibuprofen treatment
did not affect the CD45 gene expression significantly in the
cortex. The result suggests ibuprofen treatment is not able to
reduce classical activation of microglia in the cortex, and thus
neurotoxic effect of microglia is still present. Higher doses
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may have a positive outcome on cortical gene expression.
On the other hand, in the thalamus, ibuprofen not only
reduced CD45 gene expression but also reduced TGFß1 gene
expression, suggesting reduction in both classical activation
and acquired deactivation of microglia. Higher doses may have
a negative effect on thalamic gene expression. The contrasting
responses in the two brain regions to ibuprofen are unknown,
but highlight different microenvironments in the two brain
regions.
Only the arginase 1 gene expression did not change as
the result of the FPI or ibuprofen treatment, indicating that
arginase 1 gene expression is not affected by traumatic brain
injury at 7 days time point and it is independent of the COX2
pathway. An experiment in spinal cord injury has shown that
there is an increase in arginase 1 gene expression at 1 and 3
days (Kigerl, Gensel et al. 2009), which may hold true for
TBI. By 7 days post-injury, arginase 1 gene expression might
have already subsided. We have found, however, the alternative
activation is not likely to be present at 7 days post-injury and
the alternative activation process seems to be independent of
COX2 pathways.
TGFß1 can reduce expression of TNFß, IL1ß and other
proinflammatory cytokines. From this and previous studies,
TGFß1 gene expression has correlated well with TSPO
and CD45 gene expression . This result suggests that the
expression of TGFß1 might be a compensatory mechanism to
reduce classical activation process. In each experiment, gene
expression of TGFß1 is shown to increase as CD45 and TSPO
gene expression increases and vice versa.
Whether increased or decreased, ibuprofen was successful
in modulating inflammation-related gene expression in
FPI-injured rats. Despite the changes in the inflammation
gene expression, neuroplasticity genes were not modulated
by ibuprofen administration. Lack of neuroplasticity
gene expression change is possibly correlated with lack of
alternative activation of microglia (Gensel, Nakamura et
al., 2009; Kigerl, Gensel et al., 2009). The result might be
different if neuroplasticity gene expression is measured earlier.
In conclusion, at this point we have not found a relationship
between neuroplasticity gene expression and microglia
activation process. These experiments will be followed-up on by
comparing changes of microglia activation and neuroplasticity
protein quantity in ibuprofen-treated and ibuprofen-nontreated animals.
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